159 related articles for article (PubMed ID: 15289319)
1. Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression.
Bardella C; Costa B; Maggiora P; Patane' S; Olivero M; Ranzani GN; De Bortoli M; Comoglio PM; Di Renzo MF
Cancer Res; 2004 Aug; 64(15):5154-61. PubMed ID: 15289319
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
RosanĂ² L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
3. Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase.
Ma Q; Zhang K; Guin S; Zhou YQ; Wang MH
Mol Cancer; 2010 Nov; 9():307. PubMed ID: 21114864
[TBL] [Abstract][Full Text] [Related]
4. Alterations in a defined extracellular region of the RON receptor tyrosine kinase promote RON-mediated motile and invasive phenotypes in epithelial cells.
Zhang K; Zhou YQ; Yao HP; Wang MH
Int J Oncol; 2010 Jan; 36(1):255-64. PubMed ID: 19956854
[TBL] [Abstract][Full Text] [Related]
5. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
Wang MH; Yao HP; Zhou YQ
Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.
Camp ER; Yang A; Gray MJ; Fan F; Hamilton SR; Evans DB; Hooper AT; Pereira DS; Hicklin DJ; Ellis LM
Cancer; 2007 Mar; 109(6):1030-9. PubMed ID: 17311308
[TBL] [Abstract][Full Text] [Related]
7. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.
Peace BE; Hughes MJ; Degen SJ; Waltz SE
Oncogene; 2001 Sep; 20(43):6142-51. PubMed ID: 11593422
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence.
Ma Q; Zhang K; Yao HP; Zhou YQ; Padhye S; Wang MH
Int J Oncol; 2010 Jun; 36(6):1551-61. PubMed ID: 20428780
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-stimulating protein and its receptor in non-small-cell lung tumors: induction of receptor tyrosine phosphorylation and cell migration.
Willett CG; Wang MH; Emanuel RL; Graham SA; Smith DI; Shridhar V; Sugarbaker DJ; Sunday ME
Am J Respir Cell Mol Biol; 1998 Apr; 18(4):489-96. PubMed ID: 9533936
[TBL] [Abstract][Full Text] [Related]
10. Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas.
Yokoyama K; Kamata N; Fujimoto R; Tsutsumi S; Tomonari M; Taki M; Hosokawa H; Nagayama M
Int J Oncol; 2003 Apr; 22(4):891-8. PubMed ID: 12632084
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of the RON receptor tyrosine kinase in various epithelial cancers and its contribution to tumourigenic phenotypes in thyroid cancer cells.
Wang MH; Lee W; Luo YL; Weis MT; Yao HP
J Pathol; 2007 Dec; 213(4):402-11. PubMed ID: 17955509
[TBL] [Abstract][Full Text] [Related]
12. Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines.
Chen YQ; Zhou YQ; Angeloni D; Kurtz AL; Qiang XZ; Wang MH
Exp Cell Res; 2000 Nov; 261(1):229-38. PubMed ID: 11082293
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
Wang MH; Wang D; Chen YQ
Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733
[TBL] [Abstract][Full Text] [Related]
14. A novel variant of the RON receptor tyrosine kinase derived from colorectal carcinoma cells which lacks tyrosine phosphorylation but induces cell migration.
Wang D; Lao WF; Kuang YY; Geng SM; Mo LJ; He C
Exp Cell Res; 2012 Dec; 318(20):2548-58. PubMed ID: 22975341
[TBL] [Abstract][Full Text] [Related]
15. A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells.
Chakedis J; French R; Babicky M; Jaquish D; Howard H; Mose E; Lam R; Holman P; Miyamoto J; Walterscheid Z; Lowy AM
Oncogene; 2016 Jun; 35(25):3249-59. PubMed ID: 26477314
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel splicing product of the RON receptor tyrosine kinase in human colorectal carcinoma cells.
Wang MH; Kurtz AL; Chen Y
Carcinogenesis; 2000 Aug; 21(8):1507-12. PubMed ID: 10910951
[TBL] [Abstract][Full Text] [Related]
17. Activation of the RON receptor tyrosine kinase attenuates transforming growth factor-beta1-induced apoptotic death and promotes phenotypic changes in mouse intestinal epithelial cells.
Wang D; Shen Q; Xu XM; Chen YQ; Wang MH
Carcinogenesis; 2005 Jan; 26(1):27-36. PubMed ID: 15447977
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member.
O'Toole JM; Rabenau KE; Burns K; Lu D; Mangalampalli V; Balderes P; Covino N; Bassi R; Prewett M; Gottfredsen KJ; Thobe MN; Cheng Y; Li Y; Hicklin DJ; Zhu Z; Waltz SE; Hayman MJ; Ludwig DL; Pereira DS
Cancer Res; 2006 Sep; 66(18):9162-70. PubMed ID: 16982759
[TBL] [Abstract][Full Text] [Related]
19. Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein.
Wang MH; Montero-Julian FA; Dauny I; Leonard EJ
Oncogene; 1996 Nov; 13(10):2167-75. PubMed ID: 8950984
[TBL] [Abstract][Full Text] [Related]
20. A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype.
Collesi C; Santoro MM; Gaudino G; Comoglio PM
Mol Cell Biol; 1996 Oct; 16(10):5518-26. PubMed ID: 8816464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]